Medicis to Present at Piper Jaffray Health Care Conference
23 nov. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 23, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 23rd Annual Piper Jaffray Health Care Conference in New York. A...
Medicis Wins Auction for Graceway Pharmaceuticals
18 nov. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 18, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that it was the successful bidder at a bankruptcy auction conducted by Graceway Pharmaceuticals, LLC (Graceway)...
Medicis Reports Third Quarter 2011 Results
08 nov. 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues of approximately $184.7 million for the three months ended September 30, 2011, compared to revenues of...
Medicis to Present at Credit Suisse 2011 Healthcare Conference
07 nov. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Credit Suisse 2011 Healthcare Conference in Phoenix, Arizona. A...
Medicis Announces 2011 Third Quarter Conference Call and Webcast
03 nov. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2011 third quarter financial results after the market closes on Tuesday, November 8, 2011....
Medicis and Solta Announce Close of Agreement for LipoSonix(R)
01 nov. 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz. and HAYWARD, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (Medicis) (NYSE:MRX) and Solta Medical, Inc. (Solta) (Nasdaq:SLTM) today announced that the...
Photo Release -- FDA Approves Lip Indication for Medicis' Restylane(R)
11 oct. 2011 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Oct. 11, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval application (PMA)...
Medicis to Present at UBS Global Life Sciences Conference
15 sept. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 15, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 2011 UBS Global Life Sciences Conference in New York City. A...
Medicis Declares Cash Dividend
14 sept. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 14, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.08 per issued and outstanding share of...
Medicis and Solta Announce Agreement for LIPOSONIX(R)
13 sept. 2011 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz. and HAYWARD, Calif., Sept. 13, 2011 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (Medicis) (NYSE:MRX) and Solta Medical, Inc. (Solta; Solta Medical) (Nasdaq:SLTM) today...